OMAHA, Neb.
Bond Laboratories, Inc. (OTCBB:BNLB) (“Bond Labs”), an international provider of innovative and proprietary nutritional supplements for health conscious consumers, marketed primarily through its wholly owned operating division, NDS Nutrition Products (“NDS”), (www.ndsnutrition.com) today announced that NDS will expand its current product offering sold in The Republic of Singapore. Based on the overwhelmingly favorable response received to date, NDS is expanding the current product portfolio available in Singapore from 3 to 10 SKUs. In addition to increasing its current sports nutrition offerings, NDS is also introducing new products in the categories of weight loss and general nutrition.
“Our recent launch and rapid growth in Singapore further validates our international expansion strategy,” stated John S. Wilson, Bond Labs’ Chief Executive Officer. “Singapore, which supports more than 60 GNC franchise locations, is an important market for NDS and serves as an ideal staging point to facilitate further expansion in the region. I am proud of our early success in The Republic of Singapore and excited to work with our partners in the region to leverage our leading market position to drive additional growth.”
“International expansion remains a key strategic element of our long-term growth plan which is focused on solidifying and building on NDS’ reputation as an established international premium brand,” concluded Mr. Wilson.
About Bond Labs
Bond Laboratories is a manufacturer of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through NDS Nutrition Products (“NDS”), a wholly owned operating division. NDS sells over 50 different dietary supplements to promote sports nutrition, improved performance, weight loss and general health exclusively to GNC® franchises. Bond Labs is headquartered in Omaha, Nebraska. For more information, please visit http://www.bond-labs.com.
Forward-Looking Statement
Statements in this release that are forward looking involve known and unknown risks and uncertainties, which may cause the Company’s actual results in future periods to be materially different from any future performance that may be suggested in this news release. Such factors may include, but are not limited to: the ability to of the Company to continue to grow revenue; the Company’s ability to continue to achieve positive cash flow given the Company’s existing and anticipated operating and other costs; and the outcome of the Company’s pending litigation with the U.S. Department of Labor and our former President alleging violations of certain unlawful employment practices in connection with his separation from the Company. Many of these risks and uncertainties are beyond the Company’s control. Reference is made to the discussion of risk factors detailed in The Company’s filings with the Securities and Exchange Commission, including its reports on Form 10-K and 10-Q. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the dates on which they are made.
CONTACT
For Bond Laboratories, Inc.
Surety Financial Group, LLC
Bruce
Weinstein, 410-833-0078
